These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15596046)

  • 21. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.
    Lee SH; McCormick F
    J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.
    Zhu CQ; Blackhall FH; Pintilie M; Iyengar P; Liu N; Ho J; Chomiak T; Lau D; Winton T; Shepherd FA; Tsao MS
    Clin Cancer Res; 2004 Mar; 10(6):1984-91. PubMed ID: 15041716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.
    Fagan-Solis KD; Pentecost BT; Gozgit JM; Bentley BA; Marconi SM; Otis CN; Anderton DL; Schneider SS; Arcaro KF
    J Cell Physiol; 2014 Sep; 229(9):1160-9. PubMed ID: 24443386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma.
    Shapira M; Ben-Izhak O; Linn S; Futerman B; Minkov I; Hershko DD
    Cancer; 2005 Apr; 103(7):1336-46. PubMed ID: 15717322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.
    Martín-Ezquerra G; Salgado R; Toll A; Baró T; Mojal S; Yébenes M; Garcia-Muret MP; Solé F; Quitllet FA; Espinet B; Pujol RM
    Histol Histopathol; 2011 Jan; 26(1):71-7. PubMed ID: 21117028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis.
    Min YH; Cheong JW; Lee MH; Kim JY; Lee ST; Hahn JS; Ko YW
    Clin Cancer Res; 2004 Aug; 10(15):5123-30. PubMed ID: 15297415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
    Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
    Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer.
    Davidovich S; Ben-Izhak O; Shapira M; Futerman B; Hershko DD
    Breast Cancer Res; 2008; 10(4):R63. PubMed ID: 18644126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.
    Seki R; Ohshima K; Fujisaki T; Uike N; Kawano F; Gondo H; Makino S; Eto T; Moriuchi Y; Taguchi F; Kamimura T; Tsuda H; Shimoda K; Okamura T
    Ann Oncol; 2010 Apr; 21(4):833-841. PubMed ID: 19889619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.
    Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J
    J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
    Wen Y; Wang K; Yang K
    Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1.
    Ji P; Goldin L; Ren H; Sun D; Guardavaccaro D; Pagano M; Zhu L
    J Biol Chem; 2006 Aug; 281(33):24058-69. PubMed ID: 16774918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients.
    Hafez MM; Alhoshani AR; Al-Hosaini KA; Alsharari SD; Al Rejaie SS; Sayed-Ahmed MM; Al-Shabanah OA
    Asian Pac J Cancer Prev; 2015; 16(14):5807-15. PubMed ID: 26320455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
    Zhan F; Colla S; Wu X; Chen B; Stewart JP; Kuehl WM; Barlogie B; Shaughnessy JD
    Blood; 2007 Jun; 109(11):4995-5001. PubMed ID: 17303695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics.
    Li CF; Wang JM; Kang HY; Huang CK; Wang JW; Fang FM; Wang YH; Wu WR; Li SH; Yu SC; Lee JC; Lan J; Shiue YL; Wu LC; Huang HY
    Clin Cancer Res; 2012 Mar; 18(6):1598-610. PubMed ID: 22322669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.
    Katagiri Y; Hozumi Y; Kondo S
    J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.